Aniket Kaloti, M.B.B.S. (M.D.), Ph.D.

Aniket Kaloti is a Senior Managing Director at Leerink Partners focused on Biopharma Mergers & Acquisitions.

Prior to joining the Firm in 2018, Aniket spent nearly 5 years in consulting, most recently at IQVIA, advising biopharma clients on a range of strategic projects spanning corporate finance, brand and commercial strategy, business development and M&A due diligence, and financial analysis. He has advised on a number of biopharma transactions at Leerink Partners including the sale of Decibel to Regeneron, the sale of Zogenix to UCB, and the sale of Dicerna to Novo Nordisk. Earlier in his career, Aniket advised multiple biotech and health-tech startups, including with respect to raising capital through government grants and private investors. Prior to joining the industry, he was a post-doctoral scholar in the Department of Brain and Cognitive Sciences at the Massachusetts Institute of Technology.

He earned his M.B.B.S. (US M.D. Equivalent) from University of Mumbai, Masters’ in Biomedical Engineering at IIT Bombay and PhD in Neuroscience at Northwestern University.